{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:49:10Z","timestamp":1788922150233,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008628","name":"Aarhus University Department of Clinical Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018529","name":"Alkermes Plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018529","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007605","name":"Aarhus Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.psyneuen.2024.107225","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T20:36:04Z","timestamp":1729802164000},"page":"107225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Chronic olanzapine treatment leads to increased opioid receptor expression and changes in feeding regulating neurons in the female rat hypothalamus"],"prefix":"10.1016","volume":"171","author":[{"given":"Maiken","family":"Krogsbaek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick Yao","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Yarmahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeppe","family":"S\u00f8ndergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Landau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Randel","family":"Nyengaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.psyneuen.2024.107225_bib1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/oby.2006.6","article-title":"Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents","volume":"14","author":"Albaugh","year":"2006","journal-title":"Obesity"},{"issue":"5","key":"10.1016\/j.psyneuen.2024.107225_bib2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/mp.2010.33","article-title":"Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis","volume":"16","author":"Albaugh","year":"2011","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.psyneuen.2024.107225_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/schbul\/sbq053","article-title":"Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents","volume":"38","author":"Albaugh","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psyneuen.2024.107225_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/(SICI)1098-2299(199705)41:1<48::AID-DDR6>3.0.CO;2-S","article-title":"Increased Food Consumption by Clozapine, But Not by Olanzapine, in Satiated Rats","volume":"41","author":"Benvenga","year":"1997","journal-title":"Drug Dev.\u00a0Res."},{"key":"10.1016\/j.psyneuen.2024.107225_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0169-328X(99)00132-1","article-title":"\u2018mu-Opioid receptor mRNA expression in proopiomelanocortin neurons of the rat arcuate nucleus","volume":"70","author":"Bouret","year":"1999","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.psyneuen.2024.107225_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/1359786810385491","article-title":"A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality.J","volume":"24","author":"Bradley","year":"2010","journal-title":"Psychopharmacol"},{"issue":"7","key":"10.1016\/j.psyneuen.2024.107225_bib7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2165\/11589060-000000000-00000","article-title":"Weight Gain and Changes in Metabolic Variables following Olanzapine Treatment in Schizophrenia and Bipolar Disorder","volume":"31","author":"Citrome","year":"2011","journal-title":"Clin. Drug Invest."},{"issue":"10","key":"10.1016\/j.psyneuen.2024.107225_bib8","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1177\/0269881119856850","article-title":"Samidorphan mitigates olanzapine-induced weight gain and metabolic dysfunction in rats and non-human primates","volume":"33","author":"Cunningham","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.psyneuen.2024.107225_bib9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1046\/j.1365-2818.2001.00958.x","article-title":"Tissue shrinkage and unbiased stereological estimation of particle number and size","volume":"204","author":"Dorph-Petersen","year":"2001","journal-title":"\u2019, J. Microsc."},{"issue":"5","key":"10.1016\/j.psyneuen.2024.107225_bib10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/ijnp\/pyz012","article-title":"One-year treatment with olanzapine depot in female rats: Metabolic effects","volume":"22","author":"Ersland","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.psyneuen.2024.107225_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020571","article-title":"Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation","volume":"6","author":"Fern\u00f8","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.psyneuen.2024.107225_bib12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nn.4011","article-title":"A neural basis for melanocortin-4 receptor regulated appetite\u2019","volume":"18","author":"Garfield","year":"2015","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.psyneuen.2024.107225_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2818.1999.00457.x","article-title":"The efficiency of systematic sampling in stereology - Reconsidered","volume":"193","author":"Gundersen","year":"1999","journal-title":"\u2019, J. Microsc."},{"issue":"1","key":"10.1016\/j.psyneuen.2024.107225_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/jmi.12757","article-title":"Practical implementation of the planar and spatial rotator in a complex tissue: the brain","volume":"273","author":"Hasselholt","year":"2019","journal-title":"\u2019, J. Microsc."},{"issue":"9","key":"10.1016\/j.psyneuen.2024.107225_bib15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.4103\/2230-8210.105581","article-title":"PVN pathways controlling energy homeostasis","volume":"16","author":"Hill","year":"2012","journal-title":"Indian J. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.psyneuen.2024.107225_bib16","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/bcp.13945","article-title":"Trends in utilization and dosing of antipsychotic drugs in Scandinavia: Comparison of 2006 and 2016","volume":"85","author":"H\u00f8jlund","year":"2019","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.psyneuen.2024.107225_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2016.07.218","article-title":"Olanzapine-depot administration induces time-dependent changes in adipose tissue endocrine function in rats","volume":"73","author":"Horska","year":"2016","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.psyneuen.2024.107225_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bbr.2006.03.040","article-title":"Olanzapine differentially affects 5-HT2A and 2C receptor mRNA expression in the rat brain","volume":"171","author":"Huang","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.psyneuen.2024.107225_bib19","article-title":"Hypothalamic CRH neurons: A crossroad between stress and metabolism.","volume":"26","author":"Jiang","year":"2022","journal-title":"Curr. Opin. Endocr. Metab. Res"},{"issue":"9","key":"10.1016\/j.psyneuen.2024.107225_bib20","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1523\/JNEUROSCI.4744-14.2015","article-title":"Obesity is associated with decreased \u00b5-opioid but unaltered dopamine D2 receptor availability in the brain","volume":"35","author":"Karlsson","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psyneuen.2024.107225_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2022.102205","article-title":"Spatial quantification of single cell mRNA and ligand binding of the kappa opioid receptor in the rat hypothalamus","volume":"127","author":"Krogsbaek","year":"2023","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.psyneuen.2024.107225_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2023.102324","article-title":"Changes in hypothalamic mu-opioid receptor expression following acute olanzapine treatment in female rats: Implications for feeding behavior","volume":"132","author":"Krogsbaek","year":"2023","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.psyneuen.2024.107225_bib23","unstructured":"N.Y. Larsen and M. Krogsbaek, \u2018Source code for MATLAB and CellProfiler\u2019, \u3008https:\/\/github.com\/Nick7900\/fluorescent_dot_expression\/tree\/microscopy\u3009."},{"issue":"7","key":"10.1016\/j.psyneuen.2024.107225_bib24","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.euroneuro.2017.03.010","article-title":"Metabolic side effects induced by olanzapine treatment are neutralized by CB1 receptor antagonist compounds co-administration in female rats","volume":"27","author":"Lazzari","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.psyneuen.2024.107225_bib25","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1172\/JCI93362","article-title":"The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C","volume":"127","author":"Lord","year":"2017","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.psyneuen.2024.107225_bib26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1176\/appi.ajp.2018.18030280","article-title":"Mitigation of olanzapine-induced weight gain with samidorphan, an opioid antagonist: A randomized double-blind phase 2 study in patients with schizophrenia","volume":"176","author":"Martin","year":"2019","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.psyneuen.2024.107225_bib27","first-page":"401","article-title":"\u20185-HT 2A and 5-HT 2C receptors as hypothalamic targets of developmental programming in male rats","volume":"9","author":"Martin-Gronert","year":"2016","journal-title":"Dis. Model Mech."},{"issue":"5","key":"10.1016\/j.psyneuen.2024.107225_bib28","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1080\/1028415X.2020.1840049","article-title":"Brain site-specific regulation of hedonic intake by orexin and DYN peptides: role of the PVN and obesity","volume":"25","author":"Mattar","year":"2022","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.psyneuen.2024.107225_bib29","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.00005.2009","article-title":"Reward Processing by the Opioid System in the Brain\u2019","volume":"89","author":"Merrer","year":"2009","journal-title":"Physiol. Rev."},{"issue":"18","key":"10.1016\/j.psyneuen.2024.107225_bib30","first-page":"16","article-title":"The role of proopiomelanocortin (POMC) neurones in feeding behaviour","volume":"4","author":"Millington","year":"2007","journal-title":"Nutr. Metab. (Lond. )"},{"issue":"3","key":"10.1016\/j.psyneuen.2024.107225_bib31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.appet.2006.01.008","article-title":"Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration","volume":"46","author":"Minet-Ringuet","year":"2006","journal-title":"Appetite"},{"key":"10.1016\/j.psyneuen.2024.107225_bib32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000338163","article-title":"The opioid system and food intake: Homeostatic and hedonic mechanisms","volume":"5","author":"Nogueiras","year":"2012","journal-title":"Obes. Facts"},{"issue":"5","key":"10.1016\/j.psyneuen.2024.107225_bib33","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1681\/ASN.V1051100","article-title":"Stereologic Methods and Their Application in Kidney Research","volume":"10","author":"Nyengaard","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.psyneuen.2024.107225_bib34","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.104.082073","article-title":"5-Hydroxytryptamine 1A Receptors in the Paraventricular Nucleus of the Hypothalamus Mediate Oxytocin and Adrenocorticotropin Hormone Release and Some Behavioral Components of the Serotonin Syndrome.","volume":"313","author":"Osei-Owusu","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"10.1016\/j.psyneuen.2024.107225_bib35","first-page":"638","article-title":"Schizophrenia: Overview and Treatment Options\u2019","volume":"39","author":"Patel","year":"2014","journal-title":"Pharm. Ther."},{"issue":"4","key":"10.1016\/j.psyneuen.2024.107225_bib36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3803\/EnM.2016.31.4.519","article-title":"Brain regulation of energy metabolism","volume":"31","author":"Roh","year":"2016","journal-title":"Endocrinol. Metab."},{"issue":"23","key":"10.1016\/j.psyneuen.2024.107225_bib37","doi-asserted-by":"crossref","first-page":"R1111","DOI":"10.1016\/j.cub.2014.10.023","article-title":"The hypothalamus","volume":"24","author":"Saper","year":"2014","journal-title":"Curr. Biol."},{"issue":"5","key":"10.1016\/j.psyneuen.2024.107225_bib38","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/schbul\/sbn023","article-title":"Secondary effects of antipsychotics: Women at greater risk than men","volume":"35","author":"Seeman","year":"2009","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.psyneuen.2024.107225_bib39","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1586\/17446651.3.5.577","article-title":"Hypothalamic regulation of appetite","volume":"3","author":"Simpson","year":"2008","journal-title":"Expert Rev. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.psyneuen.2024.107225_bib40","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1586\/17446651.3.5.577","article-title":"Hypothalamic regulation of appetite","volume":"3","author":"Simpson","year":"2008","journal-title":"Expert Rev. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.psyneuen.2024.107225_bib41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S1461145711001271","article-title":"Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats","volume":"15","author":"Skrede","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.psyneuen.2024.107225_bib42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1017\/S1461145713000862","article-title":"Olanzapine depot formulation in rat: A step forward in modelling antipsychotic-induced metabolic adverse effects","volume":"17","author":"Skrede","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.psyneuen.2024.107225_bib43","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nn.4220","article-title":"Lateral hypothalamic circuits for feeding and reward","volume":"19","author":"Stuber","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.psyneuen.2024.107225_bib44","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/cne.903530410","article-title":"Opioid Precursor Gene Expression in the Human Hypothalamus","volume":"353","author":"Sukhov","year":"1995","journal-title":"J. Comp. Neurol."},{"issue":"4","key":"10.1016\/j.psyneuen.2024.107225_bib45","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cpdd.601","article-title":"Bioequivalence of Olanzapine Given in Combination With Samidorphan as a Bilayer Tablet (ALKS 3831) Compared With Olanzapine-Alone Tablets: Results From a Randomized, Crossover Relative Bioavailability Study","volume":"8","author":"Sun","year":"2019","journal-title":"Clin. Pharm. Drug Dev."},{"issue":"6","key":"10.1016\/j.psyneuen.2024.107225_bib46","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1242\/dmm.026609","article-title":"Hypothalamic circuits regulating appetite and energy homeostasis: Pathways to obesity\u2019, DMM","volume":"10","author":"Timper","year":"2017","journal-title":"Dis. Models Mech."},{"issue":"4","key":"10.1016\/j.psyneuen.2024.107225_bib47","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1527-3458.2000.tb00155.x","article-title":"Olanzapine: Preclinical and Clinical Profiles of a Novel Antipsychotic Agent","volume":"6","author":"Tollefson","year":"2000","journal-title":"CNS Drug Rev."},{"issue":"4","key":"10.1016\/j.psyneuen.2024.107225_bib48","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1527-3458.2000.tb00155.x","article-title":"Olanzapine: Preclinical and Clinical Profiles of a Novel Antipsychotic Agent","volume":"6","author":"Tollefson","year":"2000","journal-title":"CNS Drug Rev."},{"issue":"2","key":"10.1016\/j.psyneuen.2024.107225_bib49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/syn.21500","article-title":"Olanzapine suppresses the rewarding and discriminative stimulus effects induced by morphine","volume":"66","author":"Torigoe","year":"2012","journal-title":"Synapse"},{"issue":"34","key":"10.1016\/j.psyneuen.2024.107225_bib50","doi-asserted-by":"crossref","first-page":"8284","DOI":"10.1523\/JNEUROSCI.0976-17.2017","article-title":"Feeding releases endogenous opioids in humans","volume":"37","author":"Tuulari","year":"2017","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.psyneuen.2024.107225_bib51","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.cmet.2015.09.026","article-title":"Neuronal Regulation of Energy Homeostasis: Beyond the Hypothalamus and Feeding","volume":"22","author":"Waterson","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.psyneuen.2024.107225_bib52","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Watson","year":"2004"},{"issue":"3","key":"10.1016\/j.psyneuen.2024.107225_bib53","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cne.20557","article-title":"\u03bc-Opioid receptor mRNA expression in identified hypothalamic neurons","volume":"487","author":"Zheng","year":"2005","journal-title":"J. Comp. Neurol."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453024002701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453024002701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T02:11:32Z","timestamp":1786414292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453024002701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":53,"alternative-id":["S0306453024002701"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2024.107225","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic olanzapine treatment leads to increased opioid receptor expression and changes in feeding regulating neurons in the female rat hypothalamus","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2024.107225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107225"}}